1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Cardiac Biomarker ST2 Proves Valuable In Helping Risk Assess Heart Failure … – PharmiWeb.com (press release)

November 25, 2013Organ Failureadmin

Cardiac Biomarker ST2 Proves Valuable In Helping Risk Assess Heart Failure ...
PharmiWeb.com (press release)
Given that over 80% of heart failure patients are 65 years of age or older1 it's no wonder then that according to the American Heart Association the number of Americans with heart failure is expected to jump from just over 5 million today to 8 million ...

and more »

Post navigation

← Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus … – Wall Street Journal Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – NASDAQ →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos